fluticasone - Globe Thesis

Keyword [fluticasone] Result: 21 - 40 \| Page: 2 of 4
21.	Therapeutic Observa Of Child Eczema Treated With Fluticasone Propionate
22.	Expression And Its Significance Of Aquaporin 5 In Nasal Polyps With Or Without Allergic Rhinitis
23.	Different Doses Of Seretide Treatment Of Stable COPD And Cytokine Related To Research
24.	The Effect Of Salmeterol/fluticasone On The BODE Index Of COPD Patients
25.	The Effect Of Salmeterol/Fluticasone On Pulmonary Function And Quality Of Life In Severe Stable Chronic Obstructive Pulmonary Disease
26.	Comparing With The Efficacy And Safety Between Inhalating Salmeterol/Fluticasone50/250ug And50/500ug In Elderly Patients With Moderate To Severe Stable COPD
27.	Clinical Efficacy And Safety Of Fluticasone/Salmeterol Combination In Non-cystic Fibrosis Bronchiectasis With Irreversible Airflow Obstruction
28.	Effect Of Fluticasone/Salmeterol On Exhaled Nitric Oxide In Cough Variant Asthma Patients
29.	The Anti-inflammatory Mechanism And Therapeutic Effect Of Salmeterol/Fluticasone Propionate On COPD
30.	Research On Fluticasone Propionate Cream
31.	Study On The Effects Of Tiotropium Combined With Salmeterol/Fluticasone Propionate In Patients With Moderate To Severe Stable Chronic Obstructive Pulmonary Disease
32.	Study On Fluticasone Propionate Cream Based On O/W Emulsions Matrix
33.	Clinical Observation On The Treatment Of Vitiligo With308-nm Excimer Laser And Fluticasone Propionate Cream
34.	Sue Yellow Cough Capsule Clinical Curative Effect Evaluation For The Treatment Of Cough Variant Asthma
35.	Effect Observation On The Prevention And Pulmonary Function Improvement Of Inhaling Fluticasone Propionate For Infant Repeated Wheezing After Bronchiolitis
36.	Therapy Efficacy Of Tiotropium Combined Salmeterol/Fluticasone In Patients With Chronic Obstructive Pulmonary Disease(DOPD)
37.	Observation Of The Clinical Curative Effect On COPD Patients In Stationary Phase With The Lung And Spleen Deficiency Syndrome Treated With Liujunzi Decoction
38.	Control Study Of Different Treatment Protocol In Patients With Severe Chronic Obstructive Pulmonary Disease In Stable Phase
39.	1.Mixed Infection And Risk Factors In Children With Severe Adenovirus Pneumonia2.Observtion Efficiency Of Salmeterol Xinafoate And Flutcasone Propionate Aerosol In Childhood Asthma
40.	Effects Of ICS/LABA Combined With Ligustrazine On The Bronchopulmonary Tissue Inflammation Of Chronic Obstructive Pulmonary Disease Rat Models
<<First <Prev Next> Last>> Jump to